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Abstract. WISDOM stands for World-wide In Silico Docking On Malaria. First step 
toward enabling the in silico drug discovery pipeline on a grid infrastructure, this CPU 
consuming application generating large data flows was deployed successfully on EGEE, 
the largest grid infrastructure in the world, during the summer 2005. 46 million docking 
scores were computed in 6 weeks. The proposed demonstration presents the submission 
of in silico docking jobs at a large scale on the grid. The demonstration will use the new 
middleware stack gLite developed within the EGEE project. 
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Malaria is a dreadful disease affecting 300 million people and killing 1.5 million people 
every year [1]. Drug resistance has emerged for all classes of antimalarials except 
artemisinins. This example illustrates the real need for new drugs against neglected diseases. 
The World Health Organization declared its will to help the development of new drugs 
against neglected diseases starting from hits proposed by the fundamental researchers.  
Advance in combinatorial chemistry has paved the way for synthesizing large numbers of 
diverse chemical compounds. Thus there are millions of chemical compounds available in 
the laboratories and also in 2D, 3D electronic databases, but it is nearly impossible and very 
expensive to screen such a high number of compounds in the experimental laboratories by 
high throughput screening (HTS). Besides the high costs, the hit rate in HTS is quite low, 
about 10 to 100 per 100,000 compounds when screened on targets such as enzymes [2].  
An alternative is high throughput virtual screening by molecular docking, a technique 
which can screen millions of compounds rapidly, reliably and cost effectively. Screening 
millions of chemical compounds in silico is a complex process. Screening each compound, 
depending on structural complexity, can take from a few minutes to hours on a standard PC, 
which means screening all compounds in a single database can take years. Computation 
time can be reduced very significantly with a large grid gathering thousands of computers 
[3,4]. 
 
WISDOM (World-wide In Silico Docking On Malaria) is an European initiative to enable 
the in silico drug discovery pipeline on a grid infrastructure. Initiated and implemented by 
Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) in Germany and the 
Corpuscular Physics Laboratory (CNRS/IN2P3) of Clermont-Ferrand in France, WISDOM 
has deployed a large scale docking experiment on the EGEE [5] infrastructure. Three goals 
motivated this first experiment. The biological goal was to propose new inhibitors for a 
family of proteins produced by Plasmodium falciparum. The biomedical informatics goal 
was the deployment of in silico virtual docking on a grid infrastructure. The grid goal is the 
deployment of a CPU consuming application generating large data flows to test the grid 
operation and services. Relevant information can be found on http://wisdom.eu-egee.fr and 
http://public.eu-egee.org/files/battles-malaria-grid-wisdom.pdf. 
The first large scale docking experiment ran on the EGEE grid production service from 11 
July 2005 until 19 August 2005. It saw over 46 million docked ligands, the equivalent of 80 
years on a single PC, in about 6 weeks. Usually in silico docking is carried out on classical 
computer clusters resulting in around 100,000 docked ligands. This type of scientific 
challenge would not be possible without the grid infrastructure - 1700 computers were 
simultaneously used in 15 countries around the world. WISDOM demonstrated how grid 
computing can help drug discovery research by speeding up the whole process and reduce 
the cost to develop new drugs to treat diseases such as malaria. The sheer amount of data 
generated indicates the potential benefits of grid computing for drug discovery and indeed, 
other life science applications. Commercial software with a server license was successfully 
deployed on more than 1000 machines in the same time.  
 
First docking results show that 10% of the compounds of the database studied may be hits. 
Top scoring compounds possess basic chemical groups like thiourea, guanidino, amino-
acrolein core structure. Identified compounds are non peptidic and low molecular weight 
compounds. Future plans for the WISDOM initiative is first to process the hits again with 
molecular dynamics simulations in a grid environment. A second data challenge planned 
for the fall of 2006 is also under preparation to improve the quality of service and the 
quality of usage of the data challenge process on gLite. In silico docking at a large scale is a 
first step toward enabling the in silico drug discovery pipeline on a grid infrastructure 
against neglected diseases. 
Key issues in the pharmaceutical process include cost and time reduction in a drug 
discovery development, security and data protection, fault tolerant and robust services and 
infrastructure, and transparent and easy use of the interfaces. With the help of the grid, a 
such large scale in silico experimentation is possible. 
 
The aim of the demonstration is to show the submission of in silico docking jobs at a large 
scale on the grid using the environment Taverna [6]. The user will prepare the jobs with a 
protein target, a compounds database, a docking software and a set of parameters, submit 
them on the grid, check their status and receive their output. Demonstration conditions will 
be similar to a large scale submission of jobs to reduce the necessary time for the in silico 
docking process. The demonstration will use the new middleware stack gLite [7], 
Lightweight Middleware for Grid Computing, developed within the EGEE project.  
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